Fundamental dimension Equity attribute | ACBPeer $3.88▼-2.27% Cap $245.6MP/E -2.8x QuantScore37/100 | ACRSPeer $3.75▼-2.09% Cap $552.0MP/E -6.5x QuantScore47/100 | BIOALeader $5.10▼-7.78% Cap $192.0MP/E -2.1x QuantScore56/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
47/100 |
55/100 |
44/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 67/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 50/100 | 54/100 |
Growth Revenue / earnings growth & margins | 13/100 | 40/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | 93/100 | 80/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.8x | -6.5x | -2.1x |
Forward P/E (next FY) | -22.2x | -5.8x | -2.1x |
EV / EBITDA (TTM) | -3.7x | -7.1x | -1.3x |
Price / Sales | 1.2x | 67.2x | 18.5x |
Price / Free Cash Flow | -6.7x | -8.9x | -2.2x |
PEG ratio | 0.03 | -0.14 | 0.29 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | -11.58 (Distress) | -2.73 (Distress) | 4.07 (Safe) |
Total debt / equity | 0.04 | 0.00 | 0.01 |
Quick ratio | 2.8x | 3.5x | 17.2x |
Interest coverage | -18.0x | — | -378.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -6.6% | -58.2% | — |
Net income growth YoY | -7753.0% | +50.8% | -13.4% |
Gross margin (TTM) | 32.1% | 95.6% | 99.4% |
Operating margin (FY) | -14.6% | -975.9% | -1031.5% |
FCF margin (FY) | -11.2% | -602.0% | -915.5% |
5. Trailing price performancePrice change over period |
1M return | -5.4% | -30.3% | -27.7% |
3M return | +45.3% | -28.3% | -76.6% |
6M return | +14.5% | -12.8% | -70.1% |
Year to date | -8.1% | +24.6% | -61.5% |
1Y return | -23.8% | +74.4% | -33.2% |
3Y return | -8.9% | -24.5% | -72.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-18.71 -582.3% premium | $-0.8247 -122.0% premium | $8.84 +73.2% upside |
Wall Street consensus target | $5.92 +52.6% · range $1.00–$8.75 | $10.75 +186.7% · range $10.00–$12.00 | $23.50 +360.8% · range $8.00–$40.00 |
Consensus stance | 21% Buy57% Hold21% Sell | 81% Buy19% Hold0% Sell | 83% Buy17% Hold-0% Sell |